Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2026

The Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2026 addresses advances in hepatobiliary and pancreatic oncology, exploring multidisciplinary cancer treatment strategies, precision medicine, and emerging diagnostic and therapeutic technologies.

Key Topics

• Systemic treatment strategies for advanced hepatocellular carcinoma including immunotherapy combinations and checkpoint inhibition
• Stage-specific multidisciplinary management of hepatocellular carcinoma and cholangiocarcinoma
• Precision oncology using biomarkers and liquid biopsy for targeted therapy selection
• Management approaches for pancreatic adenocarcinoma including neoadjuvant and adjuvant treatment strategies
• Treatment of rare hepatic and pancreatic tumors including neuroendocrine and exocrine malignancies
• Artificial intelligence applications and population health strategies for early cancer detection

Who should attend

• Surgeons
• Gastroenterologists
• Medical oncologists
• Radiation oncologists
• Pathologists
• Radiologists
• Laboratory scientists
• Allied health professionals